General Surgery

A new injunction issued by a US district court, prevents Ethicon from manufacturing, marketing and selling the Harmonic ACE®+7.

GI Dynamics, Inc., developer of EndoBarrier® for treatment of obesity and type 2 diabetes, has seen its product suspended and announced falling sales.

One-year results of the TEMPO trial demonstrate that the Transoral Incisionless Fundoplication (TIF®) procedure achieved sustained elimination of all GERD symptoms and healing of esophagitis.

UK health watchdog NICE is asking for views on its plans to support a new surgical system for reducing the size of enlarged prostate glands in men.

Torax Medical is reporting the approaching completion of 5 year data collection in the clinical trial for the LINX procedure.

85% of patients reduced medication use following the MUSE minimally-invasive procedure for GERD, with 65% eliminating medication entirely after 6 months

Legal-Bay LLC, tells us that a Federal Jury in West Virginia has awarded a husband and wife $3.27 million in damages against Ethicon, Johnson & Johnson’s mesh product division in what is another loss for transvaginal mesh manufacturers

Aesculap, Inc. has expanded its Caiman® 5 Seal and Cut Technology offering with two additional lengths added to its Caiman 5mm vessel sealer device range, enabling open surgery use.

Ethicon is introducing three new endocutter and energy products at the 19th World Congress of International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO 2014).

Ethicon Endo-Surgery says its newly launched device offers surgeons improved thermal management coupled with greater precision and speed when performing resection during open procedures.

Robot-Assisted Radical Prostatectomy has only been around since the turn of the century so this study of ten year survival rates is both rare and encouraging.

Covidien plc has unveiled an advanced ablation system that offers physicians predictable results regardless of the target location or tissue type.

A newly published peer-reviewed paper concludes that Mederi Therapeutics’ Stretta therapy is a safe, effective and durable treatment for gastro esophageal reflux disease.

Dutch company Medisse says its Flexisurge post-surgical adhesion barrier film has seen use in a first patient as it commences clinical trials.

Encision Inc., a medical device company that exists to prevent dangerous stray electrosurgical burns in minimally invasive surgery, has received FDA 510(k) clearance for its AEM Endoshield™ Burn Protection System.

Intuitive Surgical, Inc. has gained CE Mark approval for its da Vinci Xi Surgical System, following its U.S. FDA clearance back in April.